Palo Alto Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6M | Sell |
75,535
-7,953
| -10% | -$2.59M | 5.24% | 7 |
|
|
2025
Q1 | $22.5M | Sell |
83,488
-57,193
| -41% | -$15.4M | 4.29% | 7 |
|
|
2024
Q4 | $33.1M | Hold |
140,681
| – | – | 5.13% | 6 |
|
|
2024
Q3 | $38.7M | Buy |
+140,681
| New | +$38.7M | 5.03% | 8 |
|
|
2024
Q2 | – | Sell |
-182,766
| Closed | -$27.3M | – | 40 |
|
|
2024
Q1 | $27.3M | Buy |
182,766
+28,329
| +18% | +$4.23M | 3.08% | 10 |
|
|
2023
Q4 | $29.6M | Buy |
+154,437
| New | +$29.6M | 2.66% | 10 |
|